{"transactions":[{"id":2161581,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant (right to buy)","published_at":"2022-09-12T16:34:34.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":513834,"price":0.0001,"value":51.3834,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The common stock warrants expire on September 8, 2027 and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held directly by Vedanta Associates-R, L.P. (\"Vedanta Associates-R\"). Vedanta Partners is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":513834,"derivative":{"exercise_price":2.4,"expiration_date":"2027-09-08","underlying":"Common Stock","underlying_shares":513834},"source":{"system":"sec-edgar","filing":"0001104659-22-099268","document":"tm2225524-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465922099268/tm2225524-1_4seq1.xml","form_type":"4"}},{"id":2161580,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant (right to buy)","published_at":"2022-09-12T16:34:34.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":869565,"price":0.0001,"value":86.9565,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The common stock warrants expire on September 8, 2027 and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held directly by Beta Operators Fund, L.P. (\"Beta Operators Fund\"). Vedanta Associates, L.P. (\"Vedanta Associates\") is the general partner of Beta Operators Fund. Vedanta Partners, LLC (\"Vedanta Partners\") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":869565,"derivative":{"exercise_price":2.4,"expiration_date":"2027-09-08","underlying":"Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001104659-22-099268","document":"tm2225524-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465922099268/tm2225524-1_4seq1.xml","form_type":"4"}},{"id":2161579,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2022-09-12T16:34:34.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":513834,"price":2.5299,"value":1299948.6366,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held directly by Vedanta Associates-R, L.P. (\"Vedanta Associates-R\"). Vedanta Partners is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":513834,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":513834},"source":{"system":"sec-edgar","filing":"0001104659-22-099268","document":"tm2225524-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465922099268/tm2225524-1_4seq1.xml","form_type":"4"}},{"id":2161578,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2022-09-12T16:34:34.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":869565,"price":2.5299,"value":2199912.4935,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the reporting person and its affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held directly by Beta Operators Fund, L.P. (\"Beta Operators Fund\"). Vedanta Associates, L.P. (\"Vedanta Associates\") is the general partner of Beta Operators Fund. Vedanta Partners, LLC (\"Vedanta Partners\") is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners. Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":869565,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001104659-22-099268","document":"tm2225524-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000110465922099268/tm2225524-1_4seq1.xml","form_type":"4"}},{"id":2684388,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2021-06-03T17:31:45.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":399000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased as a unit, with each unit consisting of one share of common stock and one warrant exercisable for 0.75 shares of common stock. The purchase price of each unit was $3.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held directly by Beta Operators Fund, L.P. (\"Beta Operators Fund\"). Vedanta Associates, L.P. (\"Vedanta Associates\") is the general partner of Beta Operators Fund. Vedanta Partners is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":399000,"derivative":{"exercise_price":4.125,"exercise_date":"2021-06-01","expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":299250},"source":{"system":"sec-edgar","filing":"0001062993-21-005353","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000106299321005353/form4.xml","form_type":"4"}},{"id":2684387,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2021-06-03T17:31:45.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":931000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased as a unit, with each unit consisting of one share of common stock and one warrant exercisable for 0.75 shares of common stock. The purchase price of each unit was $3.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held directly by Vedanta Associates-R, L.P. (\"Vedanta Associates-R\"). Vedanta Partners, LLC (\"Vedanta Partners\") is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":931000,"derivative":{"exercise_price":4.125,"exercise_date":"2021-06-01","expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":698250},"source":{"system":"sec-edgar","filing":"0001062993-21-005353","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000106299321005353/form4.xml","form_type":"4"}},{"id":2684386,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T17:31:45.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":399000,"price":3.75,"value":1496250.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased as a unit, with each unit consisting of one share of common stock and one warrant exercisable for 0.75 shares of common stock. The purchase price of each unit was $3.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held directly by Beta Operators Fund, L.P. (\"Beta Operators Fund\"). Vedanta Associates, L.P. (\"Vedanta Associates\") is the general partner of Beta Operators Fund. Vedanta Partners is the general partner of Vedanta Associates, and Parag Saxena is the majority member of Vedanta Partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of Vedanta Associates, Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":399000,"source":{"system":"sec-edgar","filing":"0001062993-21-005353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000106299321005353/form4.xml","form_type":"4"}},{"id":2684385,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":108021,"kind":"organization","name":"VEDANTA PARTNERS, LLC","position":1,"cik":"0001502216","reported_name":"VEDANTA PARTNERS, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123893,"kind":"organization","name":"Vedanta Associates-R, LP","position":2,"cik":"0001865703","reported_name":"Vedanta Associates-R, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108022,"kind":"organization","name":"VEDANTA ASSOCIATES, L.P.","position":3,"cik":"0001502222","reported_name":"VEDANTA ASSOCIATES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123894,"kind":"organization","name":"BETA OPERATORS FUND, L.P.","position":4,"cik":"0001614642","reported_name":"BETA OPERATORS FUND, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71134,"kind":"person","name":"SAXENA PARAG","position":5,"cik":"0001015823","reported_name":"SAXENA PARAG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T17:31:45.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":931000,"price":3.75,"value":3491250.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities were purchased as a unit, with each unit consisting of one share of common stock and one warrant exercisable for 0.75 shares of common stock. The purchase price of each unit was $3.75 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held directly by Vedanta Associates-R, L.P. (\"Vedanta Associates-R\"). Vedanta Partners, LLC (\"Vedanta Partners\") is the general partner of Vedanta Associates-R, and Parag Saxena is the majority member of Vedanta Partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each of Vedanta Partners and Mr. Saxena disclaim beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein."}],"balance_after":931000,"source":{"system":"sec-edgar","filing":"0001062993-21-005353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015823/000106299321005353/form4.xml","form_type":"4"}}]}